economy
January 16, 2026
This gym stock could see a boost from increase weight-loss pill use, says Stifel
Planet Fitness could be among the beneficiaries of the GLP-1 craze, according to Stifel.

TL;DR
- Stifel maintains a buy rating and $130 price target on Planet Fitness.
- GLP-1 drug users are seen as a potential source of industry membership growth.
- A study indicates approximately 50% of new GLP-1 users consider gym membership.
- Planet Fitness's brand positioning is expected to help capture a share of GLP-1 users seeking gym access.
- A new pill version of weight-loss drugs could increase accessibility and usage, potentially doubling by 2026.
- Most analysts covering Planet Fitness are bullish on the stock.
Continue reading the original article